Elaine H Zackai

Dr. Elaine H Zackai

orcid

Research Focus & Metrics

Academic Career Length

36Years (1991-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 April 2008 in Molecular Cytogenetics
Verified
Journal Article
Open access
PDF file
BBBlake C Ballif
Blake C Ballif
ATAaron Theisen
Aaron Theisen
JCJustine Coppinger
Justine Coppinger
GGGordon C Gowans
Gordon C Gowans
JHJoseph H Hersh
Joseph H Hersh
LSLisa G Shaffer
Lisa G Shaffer
Background: Interstitial deletions of 3q29 have been recently described as a microdeletion syndrome mediated by nonallelic homologous recombination between low-copy repeats resulting in an ~1.6 Mb common-sized deletion. Given the molecular mechanism causing the deletion, the reciprocal duplication is anticipated to occur with equal frequency, although only one family with this duplication has been reported. Results: In this study we describe 14 individuals with microdeletions of 3q29, including one family with a mildly affected mother and two affected children, identified among 14,698 individuals with idiopathic mental retardation who were analyzed by array CGH. Eleven individuals had typical 1.6-Mb deletions. Three individuals had deletions that flank, span, or partially overlap the commonly deleted region. Although the clinical presentations of individuals with typical-sized deletions varied, several features were present in multiple individuals, including mental retardation and microcephaly. We also identified 19 individuals with duplications of 3q29, five of which appear to be the reciprocal duplication product of the 3q29 microdeletion and 14 of which flank, span, or partially overlap the common deletion region. The clinical features of individuals with microduplications of 3q29 also varied with few common features. De novo and inherited abnormalities were found in both the microdeletion and microduplication cohorts illustrating the need for parental samples to fully characterize these abnormalities. Conclusion: Our report demonstrates that array CGH is especially suited to identify chromosome abnormalities with unclear or variable presentations.

23 January 2004 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
DZDina J. Zand
Dina J. Zand
DHDale Huff
Dale Huff
DEDavid Everman
David Everman
KRKaren Russell
Karen Russell
SSSulagna Saitta
Sulagna Saitta
EZElaine H Zackai
Elaine H Zackai

1 February 2016 in Clinical Immunology
Verified
Journal Article
Closed access
BDBeata Derfalvi
Beata Derfalvi
KMKelly Maurer
Kelly Maurer
DMDonna M. McDonald McGinn
Donna M. McDonald McGinn
EZElaine H Zackai
Elaine H Zackai
WMWenzhao Meng
Wenzhao Meng
KSKathleen E. Sullivan
Kathleen E. Sullivan

9 September 2022 in Genetics in Medicine
Verified
Journal Article
Open access
SKSayaka Kayumi
Sayaka Kayumi
LPLuis A. Pérez-Jurado
Luis A. Pérez-Jurado
MPMaría Palomares
María Palomares
SRSneha Rangu
Sneha Rangu
SSSarah E. Sheppard
Sarah E. Sheppard
MCMark Corbett
Mark Corbett
Germline loss-of-function variants in CTNNB1 cause neurodevelopmental disorder with spastic diplegia and visual defects (NEDSDV; OMIM 615075) and are the most frequent, recurrent monogenic cause of cerebral palsy (CP). We investigated the range of clinical phenotypes owing to disruptions of CTNNB1 to determine the association between NEDSDV and CP. Genetic information from 404 individuals with collectively 392 pathogenic CTNNB1 variants were ascertained for the study. From these, detailed phenotypes for 52 previously unpublished individuals were collected and combined with 68 previously published individuals with comparable clinical information. The functional effects of selected CTNNB1 missense variants were assessed using TOPFlash assay. The phenotypes associated with pathogenic CTNNB1 variants were similar. A diagnosis of CP was not significantly associated with any set of traits that defined a specific phenotypic subgroup, indicating that CP is not additional to NEDSDV. Two CTNNB1 missense variants were dominant negative regulators of WNT signaling, highlighting the utility of the TOPFlash assay to functionally assess variants. NEDSDV is a clinically homogeneous disorder irrespective of initial clinical diagnoses, including CP, or entry points for genetic testing.

27 October 2017 in Molecular Autism
Verified
Journal Article
Open access
PDF file
CCCaitlin C. Clements
Caitlin C. Clements
TWTara L. Wenger
Tara L. Wenger
AZAlisa R. Zoltowski
Alisa R. Zoltowski
JBJennifer R. Bertollo
Jennifer R. Bertollo
JMJudith S. Miller
Judith S. Miller
RSRobert T. Schultz
Robert T. Schultz
Previous studies have reported no clear critical region for medical comorbidities in children with deletions or duplications of 22q11.2. The purpose of this study was to evaluate whether individuals with small nested deletions or duplications of the LCR-A to B region of 22q11.2 show an elevated rate of autism spectrum disorder (ASD) compared to individuals with deletions or duplications that do not include this region. We recruited 46 patients with nested deletions (n = 33) or duplications (n = 13) of 22q11.2, including LCR-A to B (n del = 11), LCR-A to C (n del = 4), LCR-B to D (n del = 14; n dup = 8), LCR-C to D (n del = 4; n dup = 2), and smaller nested regions (n = 3). Parent questionnaire, record review, and, for a subset, in-person evaluation were used for ASD diagnostic classification. Rates of ASD in individuals with involvement of LCR-B to LCR-D were compared with Fisher’s exact test to LCR-A to LCR-B for deletions, and to a previously published sample of LCR-A to LCR-D for duplications. The rates of medical comorbidities and psychiatric diagnoses were determined from questionnaires and chart review. We also report group mean differences on psychiatric questionnaires. Individuals with deletions involving LCR-A to B showed a 39–44% rate of ASD compared to 0% in individuals whose deletions did not involve LCR-A to B. We observed similar rates of medical comorbidities in individuals with involvement of LCR-A to B and LCR-B to D for both duplications and deletions, consistent with prior studies. Children with nested deletions of 22q11.2 may be at greater risk for autism spectrum disorder if the region includes LCR-A to LCR-B. Replication is needed.

21 May 2012 in American Journal of Medical Genetics Part A
Verified
Journal Article
Closed access
PDF file
KIKosuke Izumi
Kosuke Izumi
SBSusan S. Brooks
Susan S. Brooks
HFHolly A. Feret
Holly A. Feret
EZElaine H Zackai
Elaine H Zackai